NHS Dudley Health Economy Medicines Formulary
Home > 8 Malignant disease and immunosuppression > 8.1 Cytotoxic drugs > 8.1.5 Other antineoplastic drugs > Macular oedema (central retinal vein occlusion) - aflibercept solution for injection NICE TAG TA305

Macular oedema (central retinal vein occlusion) - aflibercept solution for injection NICE TAG TA305

1.1 Aflibercept solution for injection is recommended as an option for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion only if the manufacturer provides aflibercept solution for injection with the discount agreed in the patient access scheme.

https://www.nice.org.uk/guidance/TA305

Site by Devopa
© Copyright 2019 NHS. All rights reserved.